Neoadjuvant or adjuvant multimodality therapy in oesophageal cancer is introduced in an effort to improve prognosis. However, in a substantial fraction of patients there is no response to this non-surgical therapy. Non-invasive imaging modalities such as computed tomography (CT), endoscopic ultrasound (EUS) and 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) have been evaluated for assessing patient response to therapy, and these are described in this review. Currently, FDG-PET seems to be the best available tool for neoadjuvant therapy response assessment in oesophageal cancer.

译文

为了改善预后,引入了食管癌的新辅助或辅助多模式疗法。但是,在很大一部分患者中,这种非手术疗法没有反应。已经评估了非侵入性成像方式,例如计算机断层扫描 (CT),内窥镜超声 (EUS) 和18f-2-氟-2-脱氧-d-葡萄糖正电子发射断层扫描 (fdg-pet),以评估患者对治疗的反应,这些在本综述中进行了描述。目前,fdg-pet似乎是食管癌新辅助治疗反应评估的最佳工具。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录